Skip to main content
SpringerLink
Log in

Neuro-oncology

  • Chapter
Atlas of Clinical Neurology

  • 4440 Accesses

Abstract

The subspecialty of neuro-oncology is a relatively young one. Many advances in diagnosis and therapy relevant to neuro-oncology have occurred within the past 25 years. Patients with brain tumors are challenging to manage and require the involvement of neurosurgeons, neuropathologists, neurologists, oncologists or neuro-oncologists, radiologists, radiation oncologists, physical medicine and rehabilitation specialists, and palliative care specialists.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2007. CA Cancer J Clin 2007, 57:43–66.

    PubMed  Google Scholar 

  2. Chamberlain MC, Kormanik PA: Practical guidelines for the treatment of malignant gliomas. West J Med 1998, 168:114–120.

    PubMed  CAS  Google Scholar 

  3. Hoffman S, Propp JM, McCarthy BJ: Temporal trends in incidence of primary brain tumors in the United States, 1985–1999. Neuro Oncol 2006, 8:27–37.

    PubMed  Google Scholar 

  4. Davis FG, Kupelian V, Freels S, et al.: Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncol 2001 3:152–158.

    PubMed  CAS  Google Scholar 

  5. Wrensch M, Minn Y, Chew T, et al.: Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 2002, 4:278–299.

    PubMed  Google Scholar 

  6. Schoenberg BS, Christine BW, Whisnant JP: The resolution of discrepancies in the reported incidence of primary brain tumors. Neurology 1978, 28:817–823.

    PubMed  CAS  Google Scholar 

  7. Pell MF, Thomas DGT: General introduction to the clinical features of malignant brain tumours. In Malignant Brain Tumours. Edited by Thomas DGT, Graham DI. London: Springer-Verlag; 1995:109–114.

    Google Scholar 

  8. Cascino GD: Epilepsy and brain tumours: implications for treatment. Epilepsia 1990, 31:537–544.

    Google Scholar 

  9. Salander P, Bergenheim AT, Hamberg K, et al.: Pathways from symptoms to medical care: a descriptive study of symptom development and obstacles to early diagnosis in brain tumour patients. Fam Pract 1999, 162:143–148.

    Google Scholar 

  10. Henry C, Despland PA, Regli F: Initial epileptic crisis after the age of 60: aetiology, clinical aspect and EEG. Schweiz Med Wochenschr 1990, 120:787–792.

    Google Scholar 

  11. Salcman M, Kaplan RS: Intracranial tumors in adults. In Comprehensive Textbook of Oncology. Edited by Moosa AR, Bobson MD, Schimpff SD. Baltimore: Williams & Wilkins; 1986:617–629.

    Google Scholar 

  12. Black P, Wen PY: Clinical, imaging and laboratory diagnosis of brain tumors. In Brain Tumors: An Encyclopedic Approach. Edited by Kaye AH, Laws ER Jr. Hong Kong: Churchill Livingstone; 1995:191–214.

    Google Scholar 

  13. Kraemer DL, Bullard DE: Clinical presentation of the brain tumor patient. In Brain Tumors: A Comprehensive Text. Edited by Morantz RA, Walsh JW. New York: Marcel Dekker; 1994:183–211.

    Google Scholar 

  14. Kleihues P, Louis DN, Scheithauer BW, et al.: The WHO classification of tumors of the nervous system. Neuropathol Exp Neurol 2002, 61:215–225.

    Google Scholar 

  15. Giles GG, Gonzales MF: Epidemiology of brain tumors and factors in prognosis. In Brain Tumors: An Encyclopedic Approach. Edited by Kaye AH, Laws ER Jr. New York: Churchill Livingstone; 1994:47–67.

    Google Scholar 

  16. Shaw EG, Daumas-Duport C, Scheithauer BW, et al.: Radiation therapy in the treatment of low-grade supratentorial astrocytomas. J Neurosurg 1989, 70:853–861.

    PubMed  CAS  Google Scholar 

  17. Guthrie BL, Laws ER Jr: Supratentorial low-grade gliomas. Neurosurg Clin North Am 1990, 1:37–48.

    CAS  Google Scholar 

  18. Daumas-Duport C, Scheithauer BW, O’Fallon JR, et al.: Grading of astrocytomas: a simple and reproducible method. Cancer 1988, 62:2152–2165.

    PubMed  CAS  Google Scholar 

  19. Laurent JJ, Webb KM, Jane JA Jr, et al.: Pituitary adenomas. In Textbook of Neuro-Oncology. Edited by Berger MS, Prados MD. Philadelphia: Elsevier; 2005:351–356.

    Google Scholar 

  20. Someya M, Sakata KI, Oouchi A, et al.: Four cases of meningeal hemangiopericytoma treated with surgery and radiotherapy. Jpn J Clin Oncol 2001, 31:548–552.

    PubMed  CAS  Google Scholar 

  21. Carew JF, Singh B, Kraus DH: Hemangiopericytoma of the head and neck. Laryngoscope 1999, 109:1409–1411.

    PubMed  CAS  Google Scholar 

  22. Segall HD, Destian S, Nelson MD Jr, et al.: CT and MR imaging in malignant gliomas. In Malignant Cerebral Glioma. Edited by Apuzzo MLJ. Park Ridge, IL: American Association of Neurological Surgeons 1991:63–78.

    Google Scholar 

  23. Salcman M: Intracranial hemorrhage caused by brain tumor. In Intracerebral Hematomas. Edited by Kaufman HH. New York: Raven Press; 1992:95–106.

    Google Scholar 

  24. Al-Okaili RN, Krejza J, Woo JH, et al.: Intraaxial brain masses: MR imaging-based diagnostic strategy-initial experience. Radiology 2007, 243:539–550.

    PubMed  Google Scholar 

  25. Leibel SA, Sheline GE: Radiation therapy for neoplasms of the brain. J Neurosurg 1987, 66:1–22.

    PubMed  CAS  Google Scholar 

  26. Valk PE, Budinger TF, Levin VA, et al.: PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome. J Neurosurg 1988, 69:830–838.

    PubMed  CAS  Google Scholar 

  27. Scharfen CO, Sneed PK, Wara WM, et al.: High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 1992, 24:583–591.

    PubMed  CAS  Google Scholar 

  28. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System, edn 2. Berlin: Springer-Verlag; 1993.

    Google Scholar 

  29. Wilson CB: Glioblastoma: the past, the present, and the future. Clin Neurosurg 1992, 38:32–48.

    PubMed  CAS  Google Scholar 

  30. Tso CL, Freije WA, Day A, et al.: Distinct transcription profiles of primary and secondary glioblastoma subgroups. Cancer Res 2006, 66:159–167.

    PubMed  CAS  Google Scholar 

  31. Maher EA, Brennan C, Wen PY, et al.: Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities. Cancer Res 2006, 66:11502–11513.

    PubMed  CAS  Google Scholar 

  32. Ohgaki H: Genetic pathways to glioblastomas. Neuropathology 2005, 25:1–7.

    PubMed  Google Scholar 

  33. Biernat W, Tohma Y, Yonekawa Y, et al.: Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas. Acta Neuropathol 1997, 94:303–309.

    PubMed  CAS  Google Scholar 

  34. Tohma Y, Gratas C, Biernat W, et al.: PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol 1998, 57:684–689.

    PubMed  CAS  Google Scholar 

  35. Macdonald D: Low grade gliomas, mixed gliomas and oligodendrogliomas. Semin Oncol 1994, 21:236–248.

    PubMed  CAS  Google Scholar 

  36. Cairncross G, Macdonald D, Ludwin S, et al.: Chemotherapy for anaplastic oligodendroglioma: National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1994, 12:2013–2021.

    PubMed  CAS  Google Scholar 

  37. Jeuken JW, Sprenger SH, Vermeer H, et al.: Chromosomal imbalances in primary oligodendroglial tumors and their recurrences: clues about malignant progression detected using comparative genomic hybridization. J Neurosurg 2002, 96:559–564.

    PubMed  Google Scholar 

  38. Ino Y, Betensky RA, Zlatescu MC, et al.: Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 2001, 7:839–845.

    PubMed  CAS  Google Scholar 

  39. Fujii K, Fujita N, Hirabuki N, et al.: Neuromas and meningiomas: evaluation of early enhancement with dynamic MR imaging. AJNR Am J Neuroradiol 1992, 13:1215–1220.

    PubMed  CAS  Google Scholar 

  40. Goldsher D, Litt AW, Pinto RS, et al.: Dural “tail” associated with meningiomas on Gd-DTPA-enhanced MR images: characteristics, differential diagnostic value, and possible implications of treatment. Radiology 1990, 176:447–450.

    PubMed  CAS  Google Scholar 

  41. Tien RD, Yang PJ, Chu PK: “Dural tail sign”: a specific MR sign for meningioma? J Comput Assist Tomogr 1991, 15:64–66.

    PubMed  CAS  Google Scholar 

  42. Chen TC, Zee CS, Miller CA, et al.: MRI and pathological correlates of meningiomas. Neurosurgery 1992, 31:1015–1022.

    PubMed  CAS  Google Scholar 

  43. Jaaskelainen J: Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. Surg Neurol 1986, 25:461–469.

    Google Scholar 

  44. DeMonte F, Al-Mefty O: Meningiomas. In Brain Tumors: An Encyclopedic Approach. Edited by Kaye AH, Laws ER Jr. Hong Kong: Churchill Livingstone; 1995:675–704.

    Google Scholar 

  45. Sherman ME, Erozan YS, Mann RB, et al.: Stereotactic brain biopsy in the diagnosis of malignant lymphoma. Am J Clin Pathol 1991, 95:878–883.

    PubMed  CAS  Google Scholar 

  46. Gavrilovic IT, Hormigo A, Yahalom J, et al.: Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol 2006, 24:4570–4574.

    PubMed  CAS  Google Scholar 

  47. Brada M, Thomas DGT: Craniopharyngioma revisited. Int J Radiat Oncol Biol Phys 1993, 27:471–475.

    PubMed  CAS  Google Scholar 

  48. Rushing EJ, Rorke LB, Sutton L: Problems in the nosology of desmoplastic tumors of childhood. Pediatr Neurosurg 1993; 19:57–62.

    PubMed  CAS  Google Scholar 

  49. Vandenberg SR: Current diagnostic concepts of astrocytic tumors. J Neuropathol Exp Neurol 1992, 51:644–657.

    PubMed  CAS  Google Scholar 

  50. Chen TC, Gonzalez-Gomez I, McComb JG: Uncommon glial tumors. In Brain Tumors. Edited by Kaye AH, Laws ER Jr. New York: Churchill Livingstone; 1995:525–557.

    Google Scholar 

  51. Mena H, Rushing EJ, Ribas JL, et al.: Tumors of pineal parenchymal cells: a correlation of histological features, including nucleolar organizer regions, with survival in 35 cases. Hum Pathol 1995, 26:20–30.

    PubMed  CAS  Google Scholar 

  52. Russell DS, Rubinstein LJ: Pathology of Tumors of the Nervous System, edn 5. Baltimore: Williams & Wilkins; 1989.

    Google Scholar 

  53. Lutterbach J, Fauchon F, Schild SE, et al.: Malignant pineal parenchymal tumors in adult patients: patterns of care and prognostic factors. Neurosurgery 2002, 51:44–56.

    PubMed  Google Scholar 

  54. Ho DM, Wong TT, Liu HC: Choroid plexus tumors in childhood: histopathologic study and clinicopathological correlation. Childs Nerv Sys 1991, 7:437–441.

    CAS  Google Scholar 

  55. Jannetta PJ: Vestibular neurilemmomas. Clin Neurosurg 1997: 44:529–548.

    PubMed  CAS  Google Scholar 

  56. Tucker T, Wolkenstain P: Association between benign and malignant peripheral nerve sheath tumors in NF1. Neurology 2005, 65:205–211.

    PubMed  CAS  Google Scholar 

  57. Roach ES: Neurocutaneous syndromes. Pediatr Clin North Am 1992, 39:591–619.

    PubMed  CAS  Google Scholar 

  58. National Institutes of Health Consensus Development Conference statement on acoustic neuroma. Dec. 11–13, 1991. Arch Neurol 1994, 51: 201–207.

    Google Scholar 

  59. Ng H, Lau K, Tse JYM, et al.: Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors. Neurosurgery 1995, 37:764–773.

    PubMed  CAS  Google Scholar 

  60. Sobel RA: Vestibular (acoustic) schwannomas: histologic features in neurofibromatosis 2 and unilateral cases. J Neuropathol Exp Neurol 1993, 52:106–113.

    PubMed  CAS  Google Scholar 

  61. Ho VB, Smirniotopoulos JG, Murphy FM, et al.: Radiologic-pathologic correlation: hemangioblastoma. AJNR Am J Neuroradiol 1992, 13:1343–1352.

    PubMed  CAS  Google Scholar 

  62. Lonser RR, Glenn GM, McClellan W, et al.: von Hippel-Lindau disease. Lancet 2003, 361:2059–2067.

    PubMed  CAS  Google Scholar 

  63. Knudson AG Jr: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971, 68:820–823.

    PubMed  Google Scholar 

  64. Wanebo JE, Lonser RR, Glenn GM, et al.: The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 2003, 98:82–94.

    PubMed  Google Scholar 

  65. Hirose T, Scheithauer BW, Lopes MBS, et al.: Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron microscopic study. Acta Neuropathol 1995, 90:387–399.

    PubMed  CAS  Google Scholar 

  66. Nixon Jr, Miller GM, Okazaki H, et al.: Cerebral tuberous sclerosis: postmortem MRI and pathologic anatomy. Mayo Clin Proc 1989, 64:305–311.

    PubMed  CAS  Google Scholar 

  67. Roach ES, Smith M, Huttenlocher P, et al.: Diagnostic criteria: tuberous sclerosis complex. Report of the Diagnostic Criteria Committee of the National Tuberous Sclerosis Association. J Child Neurol 1992, 7:221–224.

    PubMed  CAS  Google Scholar 

  68. Cohen ME, Duffner PK: Medulloblastomas. In Brain Tumors in Children. Principles of Diagnosis and Treatment. Edited by Cohen ME, Duffner PK. New York: Raven Press; 1995:177–201.

    Google Scholar 

  69. Evans RG: The role of radiation therapy in the treatment of brain tumors in children. In Brain Tumors: A Comprehensive Text. Edited by Morantz RA, Walsh JW. New York: Marcel Dekker; 1994:659–677.

    Google Scholar 

  70. Thomas DGT: Neuro-oncology: Primary Malignant Brain Tumors. Edited by Thomas DGT. Baltimore: Johns Hopkins University Press; 1990:165–167.

    Google Scholar 

  71. Wilne SH, Ferris RC, Nathwani A, et al.: The presenting features of brain tumours: a review of 200 cases. Arch Dis Child 2006, 91:502–506.

    PubMed  CAS  Google Scholar 

  72. Cohen ME, Duffner PK: Brain stem tumors. In Brain Tumors in Children. Principles of Diagnosis and Treatment. Edited by Cohen ME, Duffner PK. New York: Raven Press; 1995; 241–262.

    Google Scholar 

  73. Albright AL, Packer RJ, Zimmerman R, et al.: Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from Children’s Cancer Group. Neurosurgery 1993, 33:1026–1029.

    PubMed  CAS  Google Scholar 

  74. Artigas J, Ferszt R, Brock M, et al.: The relevance of pathological diagnosis for therapy and outcome of brain stem gliomas. Acta Neurochir 1988, 42:166–169.

    CAS  Google Scholar 

  75. Packer RJ, Sutton LN, Goldwein JW, et al.: Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 1991, 74:433–440.

    PubMed  CAS  Google Scholar 

  76. Tomita T, McClone DG: Medulloblastoma in childhood: results of radical resection and low-dose neuraxis radiation therapy. J Neurosurg 1986, 64:238–242.

    PubMed  CAS  Google Scholar 

  77. Farwell Jr, Dohrmann GJ, Flannery JT: Medulloblastoma in childhood: an epidemiological study. J Neurosurg 1984, 61:593–664.

    Google Scholar 

  78. Evans AE, Jenkin DT, Sposto R, et al.: The treatment of medulloblastoma. Results of prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 1990, 72:572–582.

    PubMed  CAS  Google Scholar 

  79. Packer RJ: Diagnosis, treatment, and outcome of primary central nervous system tumors of childhood. Curr Opin Oncol 1994, 6:240–246.

    PubMed  CAS  Google Scholar 

  80. Kovnar EH, Kellie SJ, Horowitz ME, et al.: Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastomas and other malignant embryonal tumors of the central nervous system: a phase II study. J Clin Oncol 1990, 8:330–336.

    PubMed  CAS  Google Scholar 

  81. Eberhart CG, Kepner JL, Goldthwaite PT, et al.: Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. Cancer 2002, 94:552–560.

    PubMed  Google Scholar 

  82. Friedman AH, McLendon RE, Provenzale JN, et al.: Ependymoma. In Textbook of Neuro-Oncology. Edited by Berger MS, Prados MD. Philadelphia: Elsevier; 2005:190–198.

    Google Scholar 

  83. Cohen ME, Duffner PK: Cerebellar astrocytomas. In Brain Tumors in Children. Principles of Diagnosis and Treatment. Edited by Cohen ME, Duffner PK. New York: Raven Press; 1995:203–218.

    Google Scholar 

  84. Sutton LN, Molloy PT, Sernyak H, et al.: Long-term outcome of hypothalamic/ chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg 1995, 83:583–589.

    PubMed  CAS  Google Scholar 

  85. Green SB, Byar DP, Walker MD, et al.: Comparisons of carmustine, procarbazine and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 1983, 67:123–132.

    Google Scholar 

  86. Forsyth PA, Weaver S, Fulton D, et al.: Prophylactic anticonvulsants in patients with brain tumour. Can J Neurol Sci 2003, 30:106–112.

    PubMed  Google Scholar 

  87. Fink KF: Chemotherapy and anti-epileptic drug interactions. In Handbook of Brain Tumor Chemotherapy. Edited by Newton H. Academic Press; 2006:44–57.

    Google Scholar 

  88. Lacroix M, Abi-Said D, Fourney DR, et al.: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001, 95:190–198.

    PubMed  CAS  Google Scholar 

  89. Nomiya T, Nemoto K, Kumabe T, et al.: Prognostic significance of surgery and radiation therapy in cases of anaplastic astrocytoma: retrospective analysis of 170 cases. J Neurosurg 2007, 106:575–581.

    PubMed  Google Scholar 

  90. Walker MD, Alexander E Jr, Hunt WE, et al.: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trial. J Neurosurg 1978, 49:333–343.

    PubMed  CAS  Google Scholar 

  91. Stupp R, Mason WP, van den Bent MJ, et al.: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987–996.

    PubMed  CAS  Google Scholar 

  92. Hegi ME, Diserens AC, Gorlia T, et al.: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005, 352:997–1003.

    PubMed  CAS  Google Scholar 

  93. Pope WB, Lai A, Nghiemphu P, et al.: MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy. Neurology 2006, 66:1258–1260.

    PubMed  CAS  Google Scholar 

  94. Vredenburgh JJ, Desjardins A, Herndon JE, et al.: Bevacizumab, a monoclonal antibody to vascular endothelial growth factor (VEGF), and irinotecan for treatment of malignant gliomas [ASCO abstract]. J Clin Oncol 2006, 24(18S):1506.

    Google Scholar 

  95. Wen PY, Schiff D, Kesari S, et al.: Medical management of patients with brain tumors. J Neuro Oncol 2006, 80:313–32.

    CAS  Google Scholar 

  96. Knovich MA, Lesser GJ: The management of thromboembolic disease in patients with central nervous system malignancies. Curr Treat Options Oncol 2004, 5:511–517.

    PubMed  Google Scholar 

  97. Duffner PK, Cohen ME, Thomas PRM, et al.: The long-term effects of cranial irradiation on the central nervous system. Cancer 1985, 56:1841–1846.

    PubMed  CAS  Google Scholar 

  98. Packer RJ, Sutton LN, Atkins TE, et al.: A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results. J Neurosurg 1987, 70:707–713.

    Google Scholar 

  99. Twijnstra A, Boon PJ, Lormans ACM, et al.: Neurotoxicity of prophylactic cranial irradiation in patients with small cell carcinoma of the lung. Eur J Cancer Clin Oncol 1987, 23:983–986.

    PubMed  CAS  Google Scholar 

  100. Hochberg FH, Slotnick B: Neuropsychologic impairment in astrocytoma survivors. Neurology 1980, 30:172–177.

    PubMed  CAS  Google Scholar 

  101. Constine LS, Woolf PD, Cann D, et al.: Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 1993, 328:87–94.

    PubMed  CAS  Google Scholar 

  102. Delanian S, Lefaix JL: Current management for late normal tissueinjury: radiation-induced fibrosis and necrosis. Semin Radiat Oncol 2007, 17:99–107.

    PubMed  Google Scholar 

  103. Gonzalez J, Kumar AJ, Conrad CA, et al.: Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 2007, 67:323–326.

    PubMed  CAS  Google Scholar 

  104. Valk PE, Dillon WP: Radiation injury of the brain. AJNR Am J Neuroradiol 1991, 12:45–62.

    PubMed  CAS  Google Scholar 

  105. Soffer D, Gomori JM, Siegal T, et al.: Intracranial meningiomas after high-dose irradiation. Cancer 1989, 63:1514–1519.

    PubMed  CAS  Google Scholar 

  106. Dodick DW, Mokri B, Shaw EG, et al.: Sarcomas of calvarial bones: rare remote effect of radiation therapy for brain tumors. Neurology 1994, 44:908–912.

    PubMed  CAS  Google Scholar 

  107. Posner JB: Neurologic complications of cancer. In Contemporary Neurology Series, vol 45. Philadelphia: FA Davis; 1995.

    Google Scholar 

  108. Cairncross JG, Kim JH, Posner JB: Radiation therapy for brain metastases. Ann Neurol 1980, 7:529–541.

    PubMed  CAS  Google Scholar 

  109. Young DF, Posner JB, Chu F, et al.: Rapid-course radiation therapy of cerebral metastases: results and complications. Cancer 1974, 4:1069–1076.

    Google Scholar 

  110. Patchell RA, Tibbs PA, Walsh JW, et al.: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322:494–500.

    PubMed  CAS  Google Scholar 

  111. Soffietti R, Cornu P, Delattre JY, et al.: EFNS guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol 2006, 13:674–681.

    PubMed  CAS  Google Scholar 

  112. Gaspar L, Scott C, Rotman M, et al.: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745–751.

    PubMed  CAS  Google Scholar 

  113. Sampson JH, Carter JH Jr, Friedman AH, et al.: Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998, 88:11–20.

    PubMed  CAS  Google Scholar 

  114. Patchell RA, Tibbs PA, Regine WF, et al.: Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998, 280:1485–1489.

    PubMed  CAS  Google Scholar 

  115. Peacock KH Lesser GJ: Current therapeutic approaches in patients with brain metastases. Curr Treat Options Oncol 2006, 7:479–489.

    PubMed  Google Scholar 

  116. Greenberg HS, Kim JH, Posner JB: Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol. Ann Neurol 1980, 8:361–366.

    PubMed  CAS  Google Scholar 

  117. Wasserstrom W, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982, 49:759–772.

    PubMed  CAS  Google Scholar 

  118. Choucair AK, Leven VA, Gutin PH, et al.: Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas. J Neurosurg 1986, 65:654–658.

    PubMed  CAS  Google Scholar 

  119. Furneaux HM, Rosenblum MK, Dalmau J, et al.: Selective expression of Purkinje cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 1990, 322:1844–1851.

    PubMed  CAS  Google Scholar 

  120. Hetzel DJ, Stanhope CR, O’Neil BP, et al.: Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume. Mayo Clin Proc 1990, 65:1558–1563.

    PubMed  CAS  Google Scholar 

  121. Hewett SJ, Atchison WD: Specificity of Lambert-Eaton myasthenic syndrome immunoglobulin for nerve terminal calcium channels. Brain Res 1992, 599:324–332.

    PubMed  CAS  Google Scholar 

  122. Darnell RB: Paraneoplastic neurologic disorders: windows into neuronal function and tumor immunity. Arch Neurol 2004, 61:30–32.

    PubMed  Google Scholar 

Download references

Authors
  1. Karen L. Fink
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elisabeth J. Rushing
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, USA

    Roger N. Rosenberg MD (The Abe (Brunky), Morris, and William Zale Distinguished Chair in Neurology, Professor of Neurology) (The Abe (Brunky), Morris, and William Zale Distinguished Chair in Neurology, Professor of Neurology)

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Current Medicine Group LLC, part of Springer Science+Business Media LLC

About this chapter

Cite this chapter

Fink, K.L., Rushing, E.J. (2009). Neuro-oncology. In: Rosenberg, R.N. (eds) Atlas of Clinical Neurology. Current Medicine Group. https://doi.org/10.1007/978-1-57340-359-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-57340-359-7_8

  • Publisher Name: Current Medicine Group

  • Print ISBN: 978-1-57340-283-5

  • Online ISBN: 978-1-57340-359-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation